1 / 6

Thyroid Eye Disease Treatment Market

Thyroid Eye Disease (TED), also known as Graves' ophthalmopathy or Graves' orbitopathy, is an autoimmune condition that affects the eyes in people with an overactive thyroid (Graves' disease). It is characterized by inflammation and swelling of the tissues surrounding the eyes, which can lead to a variety of eye-related symptoms and complications.

Aarav658
Télécharger la présentation

Thyroid Eye Disease Treatment Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Thyroid Eye Disease Market

  2. Segmentation (Scope) By Drug By Route of Administration • Oral • Steroids • Intravenous • Monoclonal Antibody • Topical • Others • Others © Coherent Market Insights. All Rights Reserved

  3. Key Facts • Thyroid Eye Disease (TED) treatment market is experiencing significant growth due to the increasing prevalence of thyroid disorders and the rising number of patients with thyroid eye disease. • TED is an autoimmune disorder characterized by inflammation and swelling of the tissues surrounding the eyes, leading to various eye-related symptoms. • The market for TED treatment includes various therapeutic options such as corticosteroids, immunosuppressants, radiotherapy, and surgery. © Coherent Market Insights. All Rights Reserved

  4. Market Purview • The thyroid eye disease treatment market is a rapidly growing sector within the healthcare industry. • Thyroid eye disease, also known as Graves' ophthalmopathy, is an autoimmune condition that affects the eyes and is commonly associated with thyroid disorders. • The market is primarily driven by the increasing incidence and prevalence of thyroid eye disease globally. © Coherent Market Insights. All Rights Reserved

  5. Few Leading Companies Horizon Therapeutics Bausch & Lomb Incorporated Pfizer Janssen Biotech © Coherent Market Insights. All Rights Reserved

More Related